Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) Receipt of previous ...
As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of ...
Respiratory infectious diseases, such as viral pneumonia, pose a serious threat to global public health. These diseases spread rapidly and widely, potentially causing severe complications such as ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Drug Development Insights: What New Industry Data Reveals for 2026, Upcoming Webinar Hosted by Xtalks In this free webinar, learn how today's industry trends and challenges are shaping drug ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release ...
Currently, five new compounds are in Phase I or II clinical development, and two “repurposed” drugs are in Phase III development. Progress has been made, particularly with the drug candidate TMC207, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results